Dr. Brandon Curtis Danford, MD

Dr. Danford practices at Advanced Dermasurgery Associates in Dallas, Texas.

Dr. Danford's NPI, 1669850426, was assigned on May 13, 2015. Dr. Danford graduated from OU College of Medicine in 2015. Dr. Danford holds Texas license S1583.

Dr. Danford's primary practice is Advanced Dermasurgery Associates, at 10703 Preston Rd, Dallas, TX 75230 in Dallas County. The practice phone is (214) 987-3376.

Dr. Danford's primary practice is Advanced Dermasurgery Associates in Dallas, Texas. The medical group on file is Dallas Associated Dermatologists. Dmand AI also links Dr. Danford to 1 more group practice or clinic, named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Danford practices. Vendor and product names are available with a free account.

Dermatology is Dr. Danford's primary specialty in the NPI Registry, under taxonomy code 207N00000X. Dr. Danford is board certified in dermatology by the American Board of Dermatology. Dmand AI has Dr. Danford's licenses on file in 2 states: Texas and Tennessee.

Dmand AI lists acute skin infection, benign or precancerous skin growths, cold sores or genital herpes, contact dermatitis, facial skin infection, hives, itchy rashes and joint cyst among the conditions Dr. Danford treats.

CMS data shows 1,956 Medicare services from Dr. Danford across 11 procedure codes in 2024, for 465 Medicare patients. Medicare paid $80,927 for them. Every service was in an office.

CMS counts 465 Medicare patients who saw Dr. Danford in 2024. The largest group is 65 to 74, with 251 patients. 75% of them have high cholesterol, and 63% have high blood pressure. Their average risk score is 0.88, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Danford's median patient age at 48, with 55% women.

In 2024, Dr. Danford wrote 1,031 Medicare Part D claims for 330 patients. 96% of them were for generic drugs. CMS names the drug for 892 of them, across 21 drugs with 11 or more claims each, at $66,343 in total drug cost. In 2023, CMS named 627 claims across 14 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 84 out of 100 for Dr. Danford for performance year 2024, reported as part of a group. Dr. Danford accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS counts 693 procedures of removal of skin lesions by Dr. Danford, more than 90% of the clinicians it reports for that procedure.

Melanoma (skin cancer) excision: 1 to 10 procedures (CMS shows small counts as a range)

Removal or shaving of skin growth: 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links 4 papers to Dr. Danford, published from 2014 to 2023. Dr. Danford's most frequent co-authors are Anna S. Clayton, MD, Charles Thomas Darragh, MD and Darrel Lynn Ellis, MD.

CMS Open Payments shows 968 general payments to Dr. Danford from 36 drug and device companies from 2019 to 2025. Food and beverage make up the largest share, 89% of the total. Abbvie Inc. paid the most, $3,601.

Dr. Danford graduated from OU College of Medicine in 2015. Dr. Danford is a member of AAD and TMA.

Dr. Danford is in network with 23 carriers, including Elevance, Aetna and Blue Cross Blue Shield of Michigan. PPO plans come from the most carriers, 14. Check the plan with the practice before a visit.